ISSN: 0974-2115 www.jchps.com Journal of Chemical and Pharmaceutical Sciences July - September 2016 1424 JCPS Volume 9 Issue 3 Role of imaging modalities in evaluation of stroke; towards molecular imaging probes Mohammad Ali Dayani 1 , Ayoob Rostamzadeh 2 , Mohammad Gharib Salehi 3 , Daryoush Fatehi 4 * 1 Department of Radiology, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran. 2 Department of Anatomy and Neuroscience, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran. 3 Department of Radiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. *4 Department of Medical Physics, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran. *Corresponding author: E-Mail: d.fatehi@gmail.com, Tel: +983833335652, Fax: +983813334911. ABSTRACT MRI scanners show a spatial resolution of 250 μm in-plane (small lenticel empirical devices permit for 50 μm isotropic voxels for in vivo evaluation) infinite profundity infiltration along with significant good soft tissue contrast. Extracting any new epitomizing technology to the imaging of children has a number of safety interests that must be aimed. However the lack of ionizing radiation makes MRI particularly suitable for a stroke patient. These treatments must be tailored to the individual biochemical set-up or disease stage of each respective patient with the support of diagnostic data. Equipped with these patient-specific data, a therapy regime is selected, taking into account the different molecular defects for each disease as well as the particular clinical history and condition of a patient. Neuroradiological tools such as CT or MRI have become an indispensable part of the examination and work-up of patients with acute cerebrovascular insults. KEY WORDS: Molecular imaging, central nervous system (CNS) diseases, positron emission tomography (PET). 1. INTRODUCTION Clinical MRI scanners show a spatial resolution of 250 μm in-plane (small lenticel empirical devices permit for 50 μm isotropic voxels for in vivo evaluation) infinite profundity infiltration along with significant good soft tissue contrast (Heyn, 2006). Those mentioned above about the condensation of molecular epitomizing targets in the micromolar range is challenging and requires sophisticated imaging strategies(Gharib Salehi, 2016). Progresses in MRI plan to decrease the lower examination limit are feasible only to some extent (Heyn, 2006). Therefore biophysical amplification. Mechanisms to enhance the signal from the label are necessary. For MRI, two different classes of contrast agents exist: agents that influence mainly the signal in T2W (negative contrast agents, reducing the signal) or in T1W Images (affirmative opposition factors, enhancing the symptom) (Kiessling, 2007). For both cases, some procedures have been developed to reinforce symptoms. Generally, both of the cases take advantage of either too vast relaxivity searches, background decrease (SNR optimization) by activation of low– relaxivity searches by the aimed molecular signal (persuaded alteration in relaxivity) or discourse tissue reposition. The latter is feasible with a very limited number of highly expressed molecular signals (e.g. fibrin for thrombosis imaging). The bio – distribution of molecular epitomizing searches must be more specific in detecting and distinguishing disease than the morphological information acquired using anatomical imaging alone (Kiessling, 2007). MRI has a lot of characteristics that make it a powerful device to search issue function as well as to epitomize cellular and molecular procedures (Fatehi, 2016). However, although descriptive epitomizing with MRI is well established epitomizing functional and molecular procedures with MRI has only recently been introduced into clinical practice and many applications are still in the pre-clinical stage of development. Adapting Adapting any new epitomizing to the imaging of has some safety interests that must be addressed. however the lack of ionizing radiation makes MRI particularly suitable for a stroke patient(Fatehi, 2016). Epidemiological and radiological characteristics of stroke: Stroke is the second-leading cause of death in adults aged 15 years and over worldwide, the fourth-leading cause of disease burden as measured in disability adjusted life years, and the leading cause of acquired disability in adults in most regions. Globally, an estimated 5.7 Million people died because of stroke in 2005. The estimated direct medical cost of stroke in the United States was $25 billion in 2007. The symptoms and the imaging and histopathologic findings following ischemic stroke result from insufficient flow of blood to the brain parenchyma. Most commonly, This decrease in blood current is a result of obstraction of an arterial branch supplying a part of the brain in the absence of adequate collateral circulation (Easton, 2009). Systemic factors, such as hypoperfusion because of sustained severe hypotension, can also lead to irreversible ischemic damage in the brain tissue. An occlusion of a blood vessel is typically due to arterial or paradoxical embolism, due to a local thrombotic event that is triggered by rupture of an atherosclerotic plaque or due to prothrombotic conditions. If the reduction in blood flow is of sufficient severity and duration, a series of events occurs at the cellular level that leads to irreversible changes. These events include the release of excitatory